Systemic sclerosis & Raynaud's
Results from the international collaborative systematic literature review informing the 2023 EULAR recommendations for the treatment of systemic sclerosis
Authors' conclusion
This SLR provides and summarises the highest level of evidence for the new EULAR recommendations for the treatment of SSc, providing an unprecedented comprehensive overview of recent knowledge on SSc treatments and participating in defining the future research agenda.
Study context
- Population
- Literature on treatment of systemic sclerosis (SSc) (30 searches for 30 interventions, plus 1 dedicated search for calcinosis)483 full texts evaluated
- Outcome
- Literature retrieved and included, and question types covered
Methodological detailsinternational collaborative, informing EULAR recommendations for SSc treatment
- International collaborative
- Informing EULAR recommendations for SSc treatment
Main finding
As reported in the abstract
- Abstracts retrieved on 31 March 2022
- 14 490
- Abstracts retrieved on 11 October 2022
- 2021
- New full texts evaluated
- 483
- New articles included, first search
- 172
- New articles included, second search
- 9
- Type III questions (new interventions)
- 40%
- Type II questions (new outcomes)
- 26%
Original publication
Results from the international collaborative systematic literature review informing the 2023 EULAR recommendations for the treatment of systemic sclerosis. Ann Rheum Dis. Published 2 January 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →